156 related articles for article (PubMed ID: 38638135)
1. Trends of the prevalence rate of central lymph node metastasis and multifocality in patients with low-risk papillary thyroid carcinoma after delayed thyroid surgery.
Wang P; Dong Z; Zhao S; Su Y; Zhang J; Ma Y; Diao C; Qian J; Cheng R; Liu W
Front Endocrinol (Lausanne); 2024; 15():1349272. PubMed ID: 38638135
[TBL] [Abstract][Full Text] [Related]
2. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
[TBL] [Abstract][Full Text] [Related]
4. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer.
Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z
Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study.
Zhu F; Shen YB; Li FQ; Fang Y; Hu L; Wu YJ
Medicine (Baltimore); 2016 Feb; 95(6):e2674. PubMed ID: 26871795
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Risk Factors Associated With Central Lymph Node Metastasis in Papillary Thyroid Carcinoma With cT1N0 Stage.
Zhao YZ; He NA; Ye XJ; Jin F; Li MX; Jiang X
Front Endocrinol (Lausanne); 2022; 13():880911. PubMed ID: 35733781
[TBL] [Abstract][Full Text] [Related]
7. Thyroid Lobectomy for T1 Papillary Thyroid Carcinoma in Pediatric Patients.
Sudoko CK; Jenks CM; Bauer AJ; Isaza A; Mostoufi-Moab S; Surrey LF; Bhatti TR; Franco A; Adzick NS; Kazahaya K
JAMA Otolaryngol Head Neck Surg; 2021 Nov; 147(11):943-950. PubMed ID: 34554217
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study.
Li X; Zhang H; Zhou Y; Cheng R
World J Surg Oncol; 2021 Apr; 19(1):138. PubMed ID: 33941214
[TBL] [Abstract][Full Text] [Related]
9. Bilateral multifocality is an independent predictor of patients' outcome in Middle Eastern papillary thyroid carcinoma.
Parvathareddy SK; Siraj AK; Annaiyappanaidu P; Siraj N; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Front Endocrinol (Lausanne); 2022; 13():1060301. PubMed ID: 36686467
[TBL] [Abstract][Full Text] [Related]
10. The synergic effect of BRAF
Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Liu Y; Lv H; Zhang S; Shi B; Sun Y
Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
[TBL] [Abstract][Full Text] [Related]
12. Prediction model of cervical lymph node metastasis based on clinicopathological characteristics of papillary thyroid carcinoma: a dual-center retrospective study.
Liu W; Zhang D; Jiang H; Peng J; Xu F; Shu H; Su Z; Yi T; Lv Y
Front Endocrinol (Lausanne); 2023; 14():1233929. PubMed ID: 37766691
[TBL] [Abstract][Full Text] [Related]
13. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
[TBL] [Abstract][Full Text] [Related]
14. High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma（cT1N0）.
Zhou B; Qin J
Eur J Surg Oncol; 2021 Apr; 47(4):882-887. PubMed ID: 33092967
[TBL] [Abstract][Full Text] [Related]
15. Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis.
Heng Y; Yang Z; Lin J; Liu Q; Cai W; Tao L
Oral Oncol; 2022 Nov; 134():106185. PubMed ID: 36191477
[TBL] [Abstract][Full Text] [Related]
16. Pathological multifocality is not a prognosis factor of papillary thyroid carcinoma: a single-center, retrospective study.
Omi Y; Haniu K; Kamio H; Fujimoto M; Yoshida Y; Horiuchi K; Okamoto T
World J Surg Oncol; 2022 Dec; 20(1):394. PubMed ID: 36510206
[TBL] [Abstract][Full Text] [Related]
17. Integrating US-guided FNAB, BRAF
Ma N; Tian HY; Yu ZY; Zhu X; Zhao DW
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5565-5574. PubMed ID: 37540271
[TBL] [Abstract][Full Text] [Related]
18. Central lymph nodes in frozen sections can effectively guide extended lymph node resection for papillary thyroid carcinoma.
Peng L; Zheng X; Xue Y; Huang C; Su X; Yu S
Ann Med; 2023; 55(2):2286337. PubMed ID: 38061392
[TBL] [Abstract][Full Text] [Related]
19. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
Gui CY; Qiu SL; Peng ZH; Wang M
J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
